ISEE NASDAQ
IVERIC bio, Inc.
1W: +1.6%
1M: +3.0%
3M: +47.6%
1Y: +257.0%
3Y: +702.2%
5Y: +1337.0%
$39.95
Last traded 2023-07-10 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$190M
-65.5% ▼
Net Income
-$176M
-53.8% ▼
EPS (Diluted)
$-1.45
-29.5% ▼
EBITDA
-$192M
-67.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $42M | $40M | $63M | $85M | $117M |
| SG&A Expenses | $24M | $22M | $26M | $30M | $73M |
| Operating Expenses | $65M | $61M | $89M | $115M | $190M |
| Operating Income | -$65M | -$61M | -$89M | -$115M | -$190M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $2M | $2M | $500K | $0 | $2M |
| Income Before Tax | $62M | -$59M | -$88M | -$115M | -$185M |
| Tax Expense | -$1M | -$111K | -$4M | -$284K | -$9M |
| Net Income | $63M | -$59M | -$85M | -$114M | -$176M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $1.70 | $-1.39 | $-1.14 | $-1.12 | $-1.45 |
| EBITDA | $62M | -$57M | -$88M | -$115M | -$192M |
| Shares Outstanding | 37M | 42M | 74M | 102M | 121M |